Cell Cycle · 2012 · 34 citations · 28 references
Life SciencesCancer BiologyCell BiologyCell SignalingOncogenesSignal TransductionCalcium SignalingCancer Cell SignalingIntracellular Calcium SignalingOncogenic Signaling PathwaysProtein Kinase CascadesRas Family OncogenesCalcium-calmodulin SignalingCalcium-dependent Protein Kinase IiCalmodulin-dependent Protein Kinase IiErk SignalingExtracellular Signal-regulated Kinase PathwayMap KinasesOncogenic Ras SignalingSerine Phosphorylation
The calcium/calmodulin-dependent kinase II (CaMKII) participates with Ras to Raf-1 activation, and it is necessary for activation of the extracellular signal-regulated kinase (ERK) by different factors in epithelial and mesenchimal cells. Raf-1 activation is a complex multistep process, and its maximal activation is achieved by phosphorylation at Y341 by Src and at S338 by other kinase/s. Although early data proposed the involvement of p21-activated kinase 3 (Pak3), the kinase phosphorylating S338 remains to be definitively identified. In this study, we verified the hypothesis that CaMKII phosphorylates Raf-1 at Ser338. To do so, we determined the role of CaMKII in Raf-1 and ERK activation by oncogenic Ras and other factors. Serum, fibronectin, Src (Y527) and Ras (V12) activated CaMKII and ERK, at different extents. The inhibition of CaMKII attenuated Raf-1 and ERK activation by all these factors. CaMKII was also necessary for the phosphorylation of Raf-1 at S338 by serum, fibronectin and Ras. Conversely, inhibition of Pak3 activation by blocking phosphatidylinositol 3-kinase was ineffective. The direct phosphorylation of S338 Raf-1 by CaMKII was demonstrated in vitro by interaction of purified kinases. These results demonstrate that Ras activates CaMKII, which, in turn, phosphorylates Raf-1 at S338 and participates in ERK activation upon different stimuli.
28
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Paul Wan, Mathew J. Garnett, S. Mark Roe et al. · Cell · 2004 · 2.8K citations · Full text
Raf-1 activates MAP kinase-kinase
John Kyriakis, Harald App, Xianfeng Zhang et al. · Nature · 1992 · 1.3K citations
Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
Clara Montagut, Sreenath V. Sharma, Toshi Shioda et al. · Cancer Research · 2008 · 504 citations · Full text
Medicine, Cancer Biology, Oncology +17